ZIOPHARM Oncology, Inc. (ZIOP) rose 12.96% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a drop that has seen it decline -36.79% and is now up by 30.48% since start of this year. A look at its monthly performance shows that the stock has recorded a 4.72% gain over the past 30 days. Its equity price dipped by -1.21% over the past three months which led to its overall six-month decrease to stand at -12.23%.
Experts from research firms are bullish about the near-term performance of ZIOPHARM Oncology, Inc. with most of them predicting a $4.5 price target on a short-term (12 months) basis. The average price target by the analysts will see a 84.43% rise in the stock and would lead to ZIOP’s market cap to surge to $695.43M. The stock has been rated an average 2.8, which roughly stands towards the bearish end of the spectrum. Reuters looked into the 4 analysts that track ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) and find out that 1 of them rated it as a Hold. 2 of the 3 analysts rated it as a Buy or a Strong Buy while 1 advised investors to desist from buying the stock or sell it if they already possess it.
A look at ZIOP technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 53.56 point. Its trading volume has lost -1000670 shares compared to readings over the past three months as it recently exchanged 1089330 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 2090000 shares, and this is 0.52 times the normal volume.
The price of Viavi Solutions Inc. (NASDAQ:VIAV) currently stands at $11.97 after it went up by $0.27 or 2.31% and has found a strong support at $11.8 a share. If the VIAV price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $11.62 mark would also be bad for the stock as it means that the stock would plunge by 2.92% from its current position. However, if the stock price is able to trade above the resistance point around $12.06, then it could likely surge higher to try and break the upward resistance which stands at $12.14 a share. Its average daily volatility over the past one month stands at 2.51%. The stock has plunged by 2.17% from its 52-weeks high of $11.71 which it reached on Oct. 03, 2018. In general, it is 23.89% above its 52-weeks lowest point which stands at $9.11 and this setback was observed on May. 01, 2018.
Analysts have predicted a price target for Viavi Solutions Inc. (VIAV) for 1 year and it stands at an average $13.78/share. This means that it would likely increase by 15.12% from its current position. The current price of the stock has been moving between $11.71 and $11.97. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $10.5. On the other hand, one analyst is super bullish about the price, setting a target as high as $16.
The VIAV stock Stochastic Oscillator (%D) is at 56.99%, which means that it is currently neutral. The shares P/S ratio stands at 2.6 which compares to the 1.77 recorded by the industry or the 136.8 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 17.25, which is higher than the 0 multiple of 12-month price-earnings (P/E). The company’s earnings have gone down, with a quarterly decrease rate of -23.3% over the past five years.
Analysts view Viavi Solutions Inc. (NASDAQ:VIAV) as a Hold, with 2.1 consensus rating. Reuters surveyed 10 analysts that follow VIAV and found that 1 of those analysts rated the stock as a Hold. The remaining 9 were divided, with 8 analyst rating it as a Buy or a Strong Buy while 1 analysts advised investors to desist from buying Viavi Solutions Inc. (VIAV) shares or sell it if they already own it.